While the lifting of US federal prohibition on cannabis as a recreational or even medicinal drug may seem a long way away, the wider-scale legalization of a cannabis- and hemp-derived extract cannabidiol (CBD) could be around the corner.
Back in April, federal advisors voted to recommend approval of the first prescription CBD medicine, known as Epidiolex—developed by GW Pharmaceuticals plc (OTC: GWPRF). The advisory committee to the Food and Drug Administration’s vote unanimously recommended approval. The drug used in the study was purified to 99% purity.
The recommendation preceded more federal legislation that progressed later in June, which would move to legalize hemp rich in CBD to be used in several CBD oil products. The U.S. Senate Agriculture Committee overwhelmingly endorsed the Farm Bill, known also …View the full post at: Isolating CBD Through Extraction Presents Extreme as Potential US Federal CBD Legalization Nears …
Related Articles:
Online Cannabinoid Merchants Massively Gear Up for First Officially Legal Cyber Monday
By the Numbers, 3 Reasons Why Permex Petroleum Will Grow in Value
Seafarer Announces Share Exchange with Probability & Statistics
Tidal Royalty Corp. and Diem Cannabis Complete Agreement for Massachusetts Expansion
